Authors: JiaKang Wang ChungMay Yang ChangPing Lin YinDong Shan Andy Y Lo HweiFang Tien
Publish Date: 2006/09/01
Volume: 50, Issue: 5, Pages: 474-478
Abstract
The patient was initially managed by intravenous administration of highdose methotrexate Because vitreous cells persisted after systemic chemotherapy methotrexate was given intravitreally thereafter There was only selflimited corneal epitheliopathy without major complications following intraocular injections Ocular remission was sustained during a 21month followup
Keywords: